Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations

The drug olaparib (Lynparza®) is the first treatment approved by the Food and Drug Administration for patients with metastatic breast cancer who have inherited mutations in the BRCA1 or BRCA2 genes.

from Cancer via ola Kala on Inoreader http://ift.tt/2BBO921
via IFTTT